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Introduction
Hypercalcemia is a relatively common clinical condition that can 
occur secondary to one of several etiologies. Among all causes, the 
most common are primary hyperparathyroidism and malignancy. 
Even though these two causes account for greater than 90% of 
cases, the differential diagnosis when encountering hypercalcemia 
should remain broad to in order to accurately diagnose and treat 
this potentially lethal condition. One of the less common hormonal 
abnormalities causing hypercalcaemia is an elevation in PTHrP, 
parathyroid hormone related protein.  The presence of PTHrP was 
first identified as the cause of hypercalcemia in the setting of 
malignancy. It is most associated with lung and breast cancer.  The 
protein, which mimics the effects of native parathyroid hormone, 
is usually undetectable in healthy individuals. However, recent 
studies and case reports have shown that PTHrp levels have 
been measurable during pregnancy and lactation in females and 
have disappeared or decreased after delivery. This phenomenon 
is described as humoral hypercalcemia of pregnancy, which is a 
peripartum increase in release of PTHrp by mammary and placental 
tissue. Here, we present a case of a healthy 26-year-old female who 
developed severe hypercalcemia after delivery and during breast 
feeding secondary to elevated PTHrP. 
Clinical Case: A 25 year old female presented 
to the emergency department six days post-partum of 
spontaneous vaginal delivery of twins at 28 and 4/7 weeks. 
Her chief complaints included bilateral leg pain, weakness, 
and difficulty ambulating for the previous two days. The 
patient reported complaints of recent fatigue, polyuria, and 
polydipsia. She was breastfeeding as well as pumping her 
breast milk and reported only taking pre-natal vitamins and 
occasional acetaminophen for headaches. Given her leg 
pain, venous Doppler studies of the lower extremities were 
ordered which revealed bilateral deep vein thromboses 
(DVT). A CT of the chest was also performed that revealed 
bilateral lower lobe pulmonary emboli (PE). Her calcium 
level prior to delivery was noted to be normal, however, 
on presentation, she had an elevated hypoalbuminemia-
corrected calcium of 17.14mg/dL and an elevated ionized 
calcium of 8.70 mg/dl. Her alkaline phosphatase was 
slightly elevated at 184 U/L. Her remaining electrolytes 
were all within normal limits. Her CT Chest did not reveal 
any signs of mediastinal masses. Due to her bilateral DVT 
and PE, she was started on a Heparin drip and admitted to 
the hospital. The patient was started on normal saline at 
300mL/hr and 200 units of Calcitonin two times per day for 
her severe hypercalcemia.
Upon admission, her PTH was found to be extremely low. 
Levels of Vitamin D 1,25, angiotensin converting enzyme, 
vitamin A and serum urine protein electrophoresis were 
obtained in the workup for non-PTH mediated causes of 
hypercalcemia and all were within normal ranges. Her 
PTHrP was found to be elevated to 27.0 pmol/L endorsing 
a diagnosis of rare and benign Humoral Hypercalcemia of 
Pregnancy.
The patient was treated with intravenous fluids, six days 
of calcitonin, and one dose of pamidronate. Her calcium 
normalized and she was clinically improved for discharge 
after 6 days. During her hospital course, she was bridged to 
Coumadin for anticoagulation secondary to her DVT and PE. 
To date, the patient has been lost to outpatient follow up.
Abstract
•  Calcium is actively transported through the placenta from the mother to the fetus during pregnancy. 
•  Most pregnant woman experience total hypocalcemia due to over 20g of calcium being provided 
to the developing fetus. During delivery, the calcium transport mechanism through the placenta is 
abruptly halted, which does not affect the majority of women who are total calcium depleted.    
•  Common pathologies associated with hypercalcemia are Sarcoidosis, Vitamin A overdose, 
Acromegaly, adrenal insufficiency, multiple myeloma, humoral hypercalcemia of malignancy, milk 
alkali syndrome, primary hyperparathyroidism, and less commonly humoral hypercalcemia of 
pregnancy.
•  Sarcoidosis, Vitamin A overdose, milk alkali syndrome, primary hyperparathyroidism and multiple 
myeloma were definitively ruled out. Acromegaly and adrenal insufficiency were low on the 
differential diagnosis list and would have been ruled out with tests at an outpatient office visit. 
However, of note, the patient did not have any physical exam findings of Acromegaly. Adrenal 
insufficiency was low on the differential diagnosis as the patient was not hypotensive and did not 
have any sodium or potassium irregularities.
•  Humoral hypercalcemia of pregnancy is a benign and rare entity of excessive production of PTHrP 
resulting in hypercalcemic crisis during pregnancy, puerperium, and lactation.
•  PTHrP is produced physiologically by placental tissues and mammary glands, during pregnancy and 
lactation respectively.
•  Suckling is a stimulant for prolactin secretion which stimulates PTHrP production in the mammary 
gland. When a large amount of PTHrP from the breast enters the blood stream it stimulates calcium 
to shift from maternal bone into breast milk to supply the developing newborn. If there is an 
excessive amount of PTHrP produced, this can lead to a hypercalcemic crisis during lactation.
•  Humoral hypercalcemia of pregnancy is a rare entity with no reported cases involving twin 
gestation.
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Serum Calcium 8.5-10.1 mg/dl 8.7 mg/dl 16.5 mg/dl 10.1 mg/dL 9.4 mg/dL
Albumin 3.5-4/6 g/dl 3.2 g/dl 3.3 g/dL 3.9 g/dL
Corrected Calcium 8.5-10.1 mg/dl 17.14 mg/dl 10.6 mg/dL n/a
Ionized Calcium 4.6-5.40 mg/dl 8.70 mg/dl
Phosphorus 2.3-4.6 mg/dl 2.5 mg/dl 3.1 mg/dL
Alkaline Phosphatase 25-120 U/L 184 U/L 89 U/L
PTH 14.0-72.0 pg/ml 1.7 pg/ml
PTHrP 0.0-3.4 pmol/L 27 pmol/L
Vitamin D, 25-OH 30-100 ng/mL 11 ng/mL
ACE level 9-67 U/L 38 U/L
Vitamin A, Retinol Free 0.30-1.20 mg/L 0.39 mg/L
IFG-1 87-368 ng 101 ng/ml
SPEP Ranges Negative
UPEP Ranges Negative
